Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | CES2 | O00748 | 2/20 | 0.33 |
| ▸ | CES1 | P23141 | 2/20 | 0.33 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.33 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL148576 | 0.83 | — | — | |
| SCHEMBL2438805 | 0.83 | — | — | |
| SCHEMBL29776864 | 0.81 | LMNA (0.50) | LMNACYP2A6ALDH1A1CYP3A4MAPK1 | |
| SCHEMBL3043487 | 0.79 | LMNA (0.47) | LMNACYP2A6ALDH1A1CYP3A4MAPK1 | |
| SCHEMBL8459846 | 0.73 | LMNA (0.57) | LMNACYP2A6ALDH1A1CYP3A4MAPK1 | |
| SCHEMBL2579397 | 0.73 | ALDH1A1 (0.32) | ALDH1A1CYP3A4 | |
| SCHEMBL5246070 | 0.71 | LMNA (0.53) | LMNACYP2A6ALDH1A1CYP3A4MAPK1 | |
| SCHEMBL476102 | 0.71 | ACHE (0.53) | LMNACYP2A6ALDH1A1IDO1TSHR | |
| SCHEMBL13699095 | 0.71 | TYR (0.42) | LMNAALDH1A1MAPK1IDO1KDM4E | |
| 1,4-Dichlorobenzene SCHEMBL5191 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115926587-A | Anti-corrosion wear-resistant coating and preparation method thereof | 辽宁石油化工大学 | 2023-04-07 | — | — | CN | claimed |
| CN-120040492-A | Method for synthesizing silanol by catalyzing and oxidizing silane with polyacid | 辽宁科技大学 | 2025-05-27 | — | — | CN | disclosed |
| CN-119119106-A | Method for preparing silanol by selective oxidation of hydrosilane under catalysis of nano porous palladium copper | 大连理工大学 | 2024-12-13 | — | — | CN | disclosed |
| CN-118027090-A | Method for generating silanol by oxidizing silane | 吉林大学 | 2024-05-14 | — | — | CN | disclosed |
| CN-115926587-A | Anti-corrosion wear-resistant coating and preparation method thereof | 辽宁石油化工大学 | 2023-04-07 | — | — | CN | disclosed |
| CN-115926587-A | Anti-corrosion wear-resistant coating and preparation method thereof | 辽宁石油化工大学 | 2023-04-07 | — | — | CN | disclosed |
| US-11505460-B2 | Method for producing silanol compound and hydrogen | OSAKA UNIVERISTY (JP) | 2022-11-22 | — | — | US | disclosed |
| CN-108349897-B | Trisubstituted silylphenoxyheterocycles and analogs | 拜耳作物科学股份公司 | 2022-03-04 | — | — | CN | disclosed |
| CN-112961179-A | Preparation method of borosiloxane compound | 云南民族大学 | 2021-06-15 | — | — | CN | disclosed |
| US-10927355-B2 | Method for producing an organosilicon product | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2021-02-23 | — | — | US | disclosed |
| US-5677291-A | Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols | HOECHST MARION ROUSSEL, INC. (US) | 1997-10-14 | — | — | US | disclosed |
| EP-0466183-B1 | Cyclosiloxanes with mesogenic side groups | CONSORTIUM ELEKTROCHEM IND (DE) | 1995-09-20 | — | — | EP | disclosed |
| US-5342984-A | Triorganomonohalogenosilane | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1994-08-30 | — | — | US | disclosed |
| US-5304667-A | Cyclosiloxanes containing mesogenic side groups | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 1994-04-19 | — | — | US | disclosed |
| EP-0577139-A1 | Method for preparing triorganomonohalogenosilane | Shin-Etsu Chemical Co., Ltd. (JP) | 1994-01-05 | — | — | EP | disclosed |
| US-5221759-A | CYCLOSILOXANES CONTAINING MESOGENIC SIDE GROUPS | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 1993-06-22 | — | — | US | disclosed |
| EP-0466183-A1 | Cyclosiloxanes with mesogenic side groups | Consortium für elektrochemische Industrie GmbH (DE) | 1992-01-15 | — | — | EP | disclosed |
| EP-0304720-B1 | DIMETHYLSILYL SUBSTITUTED BENZOYLCHLORIDES AND PROCESS FOR THEIR PREPARATION | Consortium für elektrochemische Industrie GmbH (DE) | 1991-06-26 | — | — | EP | disclosed |
| US-4914221-A | Dimethylsilyl-substituted benzoyl chlorides and a process for preparing the same | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 1990-04-03 | — | — | US | disclosed |
| EP-0304720-A1 | Dimethylsilyl substituted benzoylchlorides and process for their preparation | Consortium für elektrochemische Industrie GmbH (DE) | 1989-03-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10927355-B2 | Method for producing an organosilicon product | HMOX2, HMOX1, HMBS | LMNA 2819/4885CYP2A6 582/4885ALDH1A1 4117/4885 |
| US-11505460-B2 | Method for producing silanol compound and hydrogen | HVCN1, SOST, HAO2 | LMNA 4002/4885CYP2A6 3467/4885ALDH1A1 1051/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.